Jump to content [AK + s] Jump to navigation [AK + 3]

Corporate Responsibility Report 2018

TAG overview

Results

Economics

XLS

Net sales, operating result (EBIT) and research and development costs, by business sector1,2

 

  

 

  

 

  

 

  

 

€ million

  

Healthcare

  

Life Science

  

Performance Materials

  

Group

 

  

 

  

 

  

 

  

 

2017

  

 

  

 

  

 

  

 

1

As a non-operating segment, Corporate and Other is not shown here as a separate item, but rather under Segment Reporting in our 2018 Annual Report.

2

Figures comprise the continuing operations of the Group excluding the Consumer Health business.

3

Figure retroactively adjusted; see Consolidated Financial Statements in our 2018 Annual Report.

Net sales

  

6,1903

  

5,882

  

2,446

  

14,5173

Operating result (EBIT)

  

1,3373

  

834

  

689

  

2,4233

R&D costs

  

1,6003

  

241

  

225

  

2,1083

 

  

 

  

 

  

 

  

 

2018

  

 

  

 

  

 

  

 

Net sales

  

6,246

  

6,185

  

2,406

  

14,836

Operating result (EBIT)

  

731

  

1,036

  

508

  

1,727

R&D costs

  

1,686

  

249

  

242

  

2,225

to page top

Cookie Disclaimer

This website uses 'cookies' to give you the best, most relevant experience. Using this website means you’re OK with this. You can change which cookies are set at any time - and find out more about them in our cookie policy. Privacy Statement

Accept More info